Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Valmet receives a repeat automation order from Asia's largest capacity biomass power plant

Valmet Oyj's trade press release April 29, 2019 at 11:00 a.m. EET Valmet has received a repeat automation technology order from Asia's largest capacity biomass power plant owned by GS EPS Co., Ltd. Phase 2 of the Dangjin 4 Biomass Power Plant is currently under construction in the city of Dangjin, close to Seoul in South Korea. The order was included in Valmet's fourth quarter 2018 orders received. The value of the order is not disclosed. The delivery will take place at the end of 2019. Installation and commissioning will start in February 2020. The order was placed by GS Engineering &

ÅF Pöyry presents preliminary combined statement for 2018 and IFRS 16 effect on the first quarter of 2019

ÅF Pöyry’s preliminary combined statements for the new organization from the first until the fourth quarter and the full year 2018, as well as for Pöyry 2018, are now available at afconsult.com. The amounts have not been reviewed by the auditor and are based on a combination of ÅF and Pöyry.The information is made available to facilitate comparisons in connection with ÅF Pöyry’s financial reports following the combination starting in the first quarter 2019 and onwards. ÅF Pöyry presents its interim report for the first quarter on 15 May at 11.00 CEST. Net sales per division 2018: ·

Elegant Metsä Pavilion – Finnish wooden architecture in Tokyo

The wooden Metsä Pavilion is to be used by Finnish athletes and companies during the Tokyo Summer Olympics in 2020. The building will be made entirely from Metsä Wood’s Kerto® LVL (laminated veneer lumber) elements. This pavilion is an example of innovative architecture based on industrially manufactured wooden elements. The pavilion has been designed by world-renowned Finnish architect Pekka Helin from Helin & Co Architects. The pavilion will be built by Metsä Group in collaboration with Business Finland. Pekka Helin describes the design process as an interesting and challenging

AlzeCure publishes its interrim report for Q1 2019

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interrim report for the first quarter of 2019 is now available on the company’s website: https://www.alzecurepharma.se/sv/section/investerare/finansiella-rapporter/Financial information for the first quarter, 2019 · Net sales during the period amounted to SEK 0 thousand (0). · Earnings after financial items amounted to SEK -11,586 thousand (-9,624). · Earnings per share before and after dilution amounted to SEK -0.31 (-0.51). · The balance sheet total amounted to SEK 225,876 thousand (46,669) as of 3/31/2019.

Wärtsilä Fleet Operations solution to increase safety and efficiency in sensitive Arctic waters

Wärtsilä Corporation, Press release, 29 April 2019 at 10 am EESTThe technology group Wärtsilä has been contracted by Sovcomflot, Russia’s largest shipping company, to roll out a Wärtsilä Fleet Operations solution  for Sovcomflot’s fleet of Arctic shuttle tankers. The aim is to promote sustainable development, and to increase the safety and efficiency of operations in the sensitive Arctic waters. Wärtsilä will also provide a core solution for the company’s fleet operation centre. The order was booked in March 2019. The solution has been developed as a

AQ Group AB acquires Trafotek

AQ Group AB has on April 29, 2019 signed an agreement with Intera Partners Oy to acquire 100% of the shares of LTI Holding Oy with the subsidiary Trafotek Oy (“Trafotek”) in Finland and its subsidiaries Trafotek AS in Estonia, Trafotek Suzhou Co., Ltd. In China and Trafotek Power Eletronicos e Transformadores in Brazil. The purchase price is EUR 28 million on a debt free cash free basis (enterprise value). Closing is expected on June 3, 2019 under the condition that the deal is approved by the Estonian and Finnish Competition Authorities. Trafotek is a leading supplier in design and

Stronger than ever: Apply sharpens its competitive edge with IFS Applications 10

IFS helps engineering company Apply improve efficiency and delivery above expectations IFS , the global enterprise applications company, announces that the Norwegian engineering company Apply has chosen to upgrade to IFS Applications™ 10 .Apply, based in Stavanger, Norway, has been an IFS customer since 2009. The company uses IFS Applications to support its entire value chain from project management to engineering, construction, supply chain management, equipment rental, finance, HR, and HSEQ. The

New record year for Valutec – sales of 43 million after export success

Valutec continued to grow last year. During 2018, the group had a total turnover of EUR 43 million, a new record and an increase of 46 percent from last year's 29.4 million, which was itself the company's best listing. Exports accounted for 75% of turnover and for the first time in Valutec's history Central Europe was the largest market, followed by Sweden and Finland. Successes on the world market have strengthened Valutec's position as world leader in lumber drying."This is long-term work that has yielded results. We are growing in Europe, Russia and North America. One reason is that the

HCL Technologies Expands U.S. Operations with New CyberSecurity Center

Company also launches a Cybersecurity training and college hiring program in Texas Noida, India, and Frisco, Texas, April 29, 2019– HCL Technologies (HCL), a leading global technology company, today announced the launch of its CyberSecurity Fusion Center (CSFC) in Frisco, Texas. The opening of the CSFC represents the next phase in the company’s mission to support secure business growth by providing customers with a single point of contact for the enterprise security lifecycle, from detection to remediation. In addition, the CSFC reflects HCL’s commitment to the state of Texas and the

ICA to cut its food waste in half by 2025

ICA Gruppen is adopting a new Group goal for reduced food waste which calls for a halving of food waste from warehouses and stores in Sweden and the Baltic countries by 2025 compared with the base year 2016. A few key aspects for achieving this new goal include smarter purchasing algorithms, the creation of so-called circular products, and routines and tools for being able to identify at an early stage foods that are at risk of being wasted.ICA Gruppen has worked actively on reducing food waste for many years, but now the Group is adopting both a concrete goal and a methodology for

SOTKAMO SILVER: PRODUCTION RAMP-UP PROCEEDS AND THE CASH FLOW HAS BEGUN

Press release in Stockholm 29.4.2019, 8.45 o'clock. The ramp-up of the production of Silver Mine is progressing. Both production lines of the concentrating plant are running, and the production and concentrate deliveries to smelters are growing as planned. The concentrate deliveries are now expected to continue weekly. The metal contents of the concentrate are as planned. The average invoicing value of the concentrate has so far been approximately EUR 7,000 - 7,500 per tonne, calculated from the cash inflow. The production capacity has been increased to 450,000 tonnes per year. The

Hansa Biopharma expands leadership team with dedicated roles for Corporate Communications, Investor Relations and Business Development

Company strengthens its dedicated communications team with the appointment of Rolf Gulliksen as Head of Corporate Communication and Klaus Sindahl as Head of Investor Relations. Emanuel Björne, previously VP Investor Relations and Business Development, will assume a new position as VP Global Business Development to fully focus on the partnership opportunities for Hansa’s proprietary enzymology platform.Lund, Sweden, April 29, 2019 – Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that the Company

ÅF welcomes world leading Performance Venue Acoustician

ÅF Sound & Vibration appoints Dr. Thomas Scelo as Performing Arts Senior Acoustician. Thomas has extensive experience with performance venues from leading roles at Marshall Day Acoustics, most recently as partner and Managing Director for the greater Hong Kong region. Thomas will start his new role at ÅF Sound & Vibration on May 1st 2019. Thomas is a world leading performance venue acoustician with more than 40 prestigious projects in his portfolio.  Philharmonie de Paris, Melbourne's Hamer Hall and the Changsha Meixihu International Culture and Art Centre are just a few.

Interim report January - March 2019

NET ASSET VALUE AND THE LATOUR SHARE ·The net asset value rose to SEK 119 per share, compared with SEK 100 per share at the start of the year. This is an increase of 18.9 per cent. By comparison, the Stockholm Stock Exchange's Total Return Index (SIXRX) increased by 13.2 per cent. The net asset value was SEK 124 per share at 26 April. 1) ·The total return on the Latour share was 11.2 per cent during the year measured against the SIXRX, which rose 13.2 per cent. INDUSTRIAL OPERATIONS ·The industrial operations' order intake rose 22 per cent to SEK 3,332 m (2,723 m),

INVISIO: Invitation to Q1 2019 conference call on May 6 at 10.00 CEST

INVISIO is pleased to invite press, investors and analysts to a conference call on May 6 at 10.00 CEST where CEO Lars Højgård Hansen present the INVISIO 2019 first quarter results.The conference call, which will be held in English, will begin with a presentation of the interim results followed by a Q&A session.The interim report will be announced on May 2, 2019.Phone number for the conference:To participate in the conference call, use the dial-in numbers below. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start.Sweden: +46 (0)8 5069

OKEA prepares for its first drilling operation to target further upside potential within and surrounding the Draugen field

Trondheim, 29th of April 2019: OKEA has on behalf of PL093, secured the semi-submersible rig Deepsea Nordkapp to drill for upside opportunities within and surrounding the Draugen field. The drilling operation is expected to commence in Q4 2019. Deepsea Nordkapp will drill one infill pilot well in the Draugen field and one exploration well in the “Skumnisse” prospect, north-east of Draugen, both within the OKEA-operated PL093 license. Deepsea Nordkapp is a 6th generation dynamically positioned harsh environment and winterized semi-submersible drilling rig on a two-year lease

PowerCell and Bosch sign joint development and licensing agreement regarding PowerCell S3

PowerCell and Robert Bosch GmbH have signed an agreement regarding the development, production and sale of the PowerCell S3 fuel cell stack for the automotive segment. The agreement includes a joint development of the S3 and a license whereby Bosch gets the exclusive right to produce and sell the new and improved version of PowerCell S3 for automotive applications such as cars, trucks and buses. Bosch will pay PowerCell MEUR 50 (approx. MSEK 530) for the license and a royalty fee for every product sold.The MEUR 50 payment will have a positive impact on the operating income for the second

Financial Report January - March 2019

Financial Summary - Q1'19 · Consolidated Net Sales $494 million · Net Sales growth (17)%, Organic Sales1 growth (12)%  · Active Safety Net Sales growth (10)%, Organic Sales1 growth (3)%  2019 Outlook  · Light vehicle production decline low to mid single digits versus 2018 · Organic Sales1 decline in the mid single digits versus 2018 · Currency translation impact on sales unchanged at ~(2)% versus 2018 · Operating loss, cash flow weaker in H1'19, expected improvement in H2'19 Business Highlights · Veoneer Order Book at the beginning of 2019 was more than

XVIVO has received market approval (PMA) from the FDA for STEEN Solution™ and XPS™

On April 26, 2019 XVIVO received Premarket approval (PMA) from the FDA for the products XPS™ and STEEN Solution™ for sale on the American market. The approval means that STEEN Solution™, XPS™ and the accompanying single-use articles are the only medical device products that are approved for Ex Vivo Lung Perfusion (EVLP) of initially unacceptable donated lungs at body temperature. This press release is an updated version of the press release sent April 27, 2019 at 12:30 a.m.Please see FDA press release on the following link:https://www.fda.gov/news-events/press-announcements/fda-approves-

Summa Equity wins ESG Award at the Private Equity Awards 2019

Summa Equity won the Environmental, Social and Governance (ESG) Award at the Private Equity Awards 2019 for incorporating the Sustainable Development Goal (SDG) framework in shaping the long-term strategy of its portfolio companies, measuring the effect and innovating to address the global challenges.   “We are honored to win the Environmental, Social and Governance Award at the Private Equity Awards 2019, one of the oldest and most respected tributes in our industry,” says Reynir Indahl, Managing Partner of Summa Equity. “To outperform, one cannot be agnostic to the challenges we as a

Follicum files patent application for new topical formulation of FOL-005 for hair loss

Using easy-to-apply cream instead of direct scalp injection would extend patent protection by 8 years Follicum AB ("Follicum" or "the company") today announced that the company's hair  loss treatment projects are progressing according to plan and a patent application for an internally developed formulation of FOL-005 has been submitted.  The cream formulation is intended to be lubricated into the scalp and has demonstrated good hair-stimulating effect in an animal model. The next step involves running a clinical phase II study in alopecia patients which is expected to start at the end of

Invitation to presentation of BioArctic’s Interim Report for the first quarter of 2019 on May 9, at 9.30 a.m. CET

Stockholm, Sweden, April 29, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) to publish the company’s Interim Report for the period January – March 2019 on Thursday,May 9, 2019 at 08:00 a.m. CET. BioArctic invites to an audiocast with teleconference (in English) for investors, analysts and media on May 9, at 09:30 – 10:30 a.m. CET. Gunilla Osswald, CEO, and Jan Mattsson, CFO, to present BioArctic and comment on the Interim Report for the first quarter of 2019 followed by a Q&A-session. Sweden: + 46 8 505 583 53Denmark: + 45 781 501 07Germany: + 49 692 222 203 80The

Lynparza receives positive EU CHMP opinion for 1st

29 April 2019 07:00 BST Lynparza receives positive EU CHMP opinion for 1st-linemaintenance treatment of BRCA-mutated advanced ovarian cancer AstraZeneca and MSD's Lynparza is the only PARP inhibitor to demonstratean improvement in progression-free survival for patients in this setting AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion, recommending Lynparza(olaparib) as a 1st-line

Nitro Games Oyj: Interim Report Jan – Mar 2019

Reporting period January – March 2019 · Revenues (Jan - Mar): 25,2 KEUR (571,0 KEUR on corresponding period 2018). · EBITDA: – 1 315,5 KEUR (- 953,6 KEUR). · EBIT: –1 472,1 KEUR (-1 110,3 KEUR). · Net profit: –1 474,9 KEUR (-1 114,7 KEUR). · Cash and cash equivalents: 2 029,8 KEUR (31 March 2019). · Short-term receivables: 168,6 KEUR (31 March 2019). Significant events during January – March 2019 · Started cooperation negotiations: streamlining organization and teams, executing cost savings. · New roadmap for Heroes of Warland: First updates were released

There are no items matching the current filter
There are no more items matching the current filter
Back to top